Last Updated : March 19, 2014
Details
FilesGeneric Name:
Everolimus
Project Status:
Complete
Therapeutic Area:
Subependymal giant cell astrocytoma associated with tuberous sclerosis complex
Manufacturer:
Novartis Pharmaceuticals Canada Inc.
Call for patient/clinician input open:
Brand Name:
Afinitor
Project Line:
Reimbursement Review
Project Number:
SR0376-000
Call for patient/clinician input closed:
NOC Status at Filing:
Post NOC
Performance Metric:
N/A — Predated performance metrics
Submission Type:
Initial
Indications:
Subependymal giant cell astrocytoma associated with tuberous sclerosis complex
Recommendation Type:
Do not list
Final Recommendation:
Files
Last Updated : March 19, 2014